Tag-Archive for ◊ Imaging / Diagnostics ◊

• Monday, February 03rd, 2014

Melanoma Diagnostic Provider, MELA Sciences, to Raise $12.45 Million in Private Placement to Institutional Investors and MELA Sciences Directors MELA Sciences, Inc. (NASDAQ: MELA), (the Company) developer of MelaFind, an FDA approved optical diagnostic device that assists dermatologists in melanoma diagnosis, today announced it has entered into definitive agreements with institutional investors and management for […]

• Wednesday, January 22nd, 2014

P-Cure signed a development deal with Philips Healthcare to advance its proton therapy using Philips imaging technology. Philips (NYSE:PHG) aligned itself with Israel-based medical device company P-Cure, in order to advance the smaller firm’s proton therapy technology. P-Cure develops low-cost proton therapy systems, which are smaller, cheaper radiation therapy system for targeting cancerous tumors. Founded in […]

• Thursday, December 12th, 2013

Hologic, Inc. (HOLX) Expands Its Board Of Directors With Appointment Of Two Independent Directors And BEDFORD, Mass., Dec. 9, 2013 /PRNewswire/ — Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, today […]

• Tuesday, December 03rd, 2013

STAMFORD, Conn.–(BUSINESS WIRE)– (Booth #2539 South Building)-FUJIFILM Medical Systems U.S.A., Inc. announced today 510(k)clearance from the U.S Food and Drug Administration (FDA) of its Gadolinium and Cesium digital X-ray detectors for pediatric use. Sizes that are available include: 24x30cm, 14×17 and 17×17. The smallest format 24x30cm cesium iodide detector is specifically designed to offer high […]

• Friday, November 22nd, 2013

Hologic Inc. (HOLX), a maker of cervical cancer and breast biopsy tools, adopted a shareholder’s rights plan after billionaire investor Carl Icahn reported a 13 percent stake in the company and said he may seek board seats. The rights plan is designed to make sure all shareholders are “appropriately compensated” and the board has time to make […]

• Tuesday, November 19th, 2013

An automated system developed by researchers from the Regenstrief Institute and Indiana University to help pediatricians focus on the specific health needs of each patient in the short time allotted for preventive care improves autism screening rates by identifying at-risk children at the 24-month visit. Nationwide children typically are not diagnosed with autism until age 4½ or […]

• Friday, November 15th, 2013

Johnson & Johnson officials reveal to MassDevice.com plans to restructure its diabetes division to “get in front” of pricing and reimbursement pressures, saying an unspecified number of layoffs will occur. Johnson & Johnson (NYSE:JNJ) told MassDevice.com today that it plans to make an unspecified number of job cuts, consolidate facilities and change the reporting structure on some of the sales […]

• Friday, November 15th, 2013

Analyst say that diagnostics maker Volcano is looking more and more like an attractive target for the likes of Medtronic or Abbott Labs. MASSDEVICE ON CALL — Diagnostics and stents maker Volcano (NSDQ:VOLC) may be primed for acquisition, with a raft of analysts’ groups debating only the timing of a buy. Volcano’s stents and stent placement and evaluation […]

• Wednesday, November 13th, 2013

IRVINE, CA–(Marketwired – November 11, 2013) – BIOLASE, Inc. (NASDAQ: BIOL), the world’s leading manufacturer and distributor of dental lasers, and a pioneer in laser surgery in other medical specialties, today announced that its Board of Directors (“Board”) has authorized BIOLASE to seek the services of an investment bank to explore possible M&A transactions with the […]

• Tuesday, November 12th, 2013

SonoSite Announces 510(k) Clearance for the World’s First Ultrasound Kiosk, the X-Porte BOTHELL, Wash.–(BUSINESS WIRE)– FUJIFILM SonoSite, Inc., specialists in designing cutting-edge ultrasound tools and world-leading education for access to point-of-care visualization, today announced it received 510(k) clearance from the FDA for its newest generation of point-of-care ultrasound: the X-Porte Ultrasound Kiosk. Available in a […]